The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Getting the “Kill” into “Shock and Kill”: Strategies to Eliminate Latent HIV
Open accessAbstract
Despite the success of antiretroviral therapy (ART), there is currently no HIV cure and treatment is lifelong. HIV persists during ART due to long lived and proliferating latently infected CD4+ T-cells. One strategy to eliminate latency is to activate virus production using latency reversing agents (LRAs) with the goal of triggering cell death through virus-induced cytolysis or immune-mediated clearance. However, multiple studies have demonstrated that activation of viral transcription alone is insufficient to induce cell death and some LRAs may counteract cell death by promoting cell survival. Here, we review new approaches to induce death of latently infected cells through apoptosis and inhibition of pathways critical for cell survival, which are often hijacked by HIV proteins. Given advances in the commercial development of compounds that induce apoptosis in cancer chemotherapy, these agents could move rapidly into clinical trials, either alone or in combination with LRAs, to eliminate latent HIV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Apoptosis and Molecular Targeting Therapy in Cancer
Hassan, M., Watari, H., AbuAlmaaty, A., Ohba, Y., & Sakuragi, N. (2014) · BioMed Research International · doi:10.1155/2014/150845 · Cited by 1,121
RetractedApoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853
The Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332
Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
Li, H., Zhu, H., Xu, C.-J., & Yuan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81590-1 · Cited by 4,445
Luo, X., Budihardjo, I., Zou, H., Slaughter, C., & Wang, X. (1998) · Cell · doi:10.1016/s0092-8674(00)81589-5 · Cited by 3,626
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
Czabotar, P. E., Lessene, G., Strasser, A., & Adams, J. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3722 · Cited by 3,219
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Mogensen, T. H. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-08 · Cited by 3,111
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Souers, A. J., Leverson, J. D., Boghaert, E. R., Ackler, S. L., Catron, N. D., Chen, J., Dayton, B. D., Ding, H., Enschede, S. H., Fairbrother, W. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3048 · Cited by 3,058
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4650-4655.1994 · Cited by 2,495
Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H., & Peter, M. E. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00245.x · Cited by 2,184
Necroptosis and its role in inflammation
Pasparakis, M., & Vandenabeele, P. (2015) · Nature · doi:10.1038/nature14191 · Cited by 2,148
Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine · doi:10.1038/8394 · Cited by 2,119
Death and anti-death: tumour resistance to apoptosis
Igney, F. H., & Krammer, P. H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc776 · Cited by 2,075
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
Chun, T.-W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T. C., et al. (1997) · Nature · doi:10.1038/387183a0 · Cited by 2,050 · cited 2×
“HIV latency is defined as the persistence of integrated HIV DNA (Koup et al, 1994; Pedersen et al, 1989) that is transcriptionally silent but replication competent (Chun et al, 1995; Chun et al, 1997b).”
BackgroundPresence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
Chun, T.-W., Stuyver, L., Mizell, S. B., Ehler, L. A., Mican, J. A. M., Baseler, M., Lloyd, A. L., Nowak, M. A., & Fauci, A. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13193 · Cited by 1,977
Holler, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.-L., Schneider, P., Seed, B., & Tschopp, J. (2000) · Nature Immunology · doi:10.1038/82732 · Cited by 1,938
Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., & Huang, D. C. S. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.030 · Cited by 1,816
The emerging mechanisms of isoform-specific PI3K signalling
Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M., & Bilanges, B. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2882 · Cited by 1,767
Regulated necrosis: the expanding network of non-apoptotic cell death pathways
Berghe, T. V., Linkermann, A., Jouan-Lanhouet, S., Walczak, H., & Vandenabeele, P. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3737 · Cited by 1,735 · cited 1×
“In the absence of caspase-8, RIPK1 assembles with RIPK3 to form a complex termed the necrosome, acting as the signal transducer for necroptosis (Vanden Berghe et al, 2014).”
BackgroundSiliciano, J. D., Kajdas, J., Finzi, D., Quinn, T. C., Chadwick, K., Margolick, J. B., Kovacs, C., Gange, S. J., & Siliciano, R. F. (2003) · Nature Medicine · doi:10.1038/nm880 · Cited by 1,703
Letai, A., Bassik, M. C., Walensky, L. D., Sorcinelli, M. D., Weiler, S., & Korsmeyer, S. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00127-7 · Cited by 1,677
Wang, H., Sun, L., Su, L., Rizo, J., Liu, L., Wang, L.-F., Wang, F.-S., & Wang, X. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.003 · Cited by 1,563
Bid, Bax, and Lipids Cooperate to Form Supramolecular Openings in the Outer Mitochondrial Membrane
Kuwana, T., Mackey, M. R., Perkins, G., Ellisman, M. H., Latterich, M., Schneiter, R., Green, D. R., & Newmeyer, D. D. (2002) · Cell · doi:10.1016/s0092-8674(02)01036-x · Cited by 1,478
Cell Type-Specific Involvement of RIG-I in Antiviral Response
Kato, H., Sato, S., Yoneyama, M., Yamamoto, M., Uematsu, S., Matsui, K., Tsujimura, T., Takeda, K., Fujita, T., Takeuchi, O., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.04.010 · Cited by 1,368
Certo, M., Moore, V. D. G., Nishino, M., Wei, G., Korsmeyer, S., Armstrong, S. A., & Letai, A. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.027 · Cited by 1,288
Kuwana, T., Bouchier-Hayes, L., Chipuk, J. E., Bonzon, C., Sullivan, B. A., Green, D. R., & Newmeyer, D. D. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.003 · Cited by 1,185
Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection
Doitsh, G., Galloway, N. L. K., Geng, X., Yang, Z., Monroe, K. M., Zepeda, O., Hunt, P. W., Hatano, H., Sowinski, S., Muñoz-Arias, I., et al. (2014) · Nature · doi:10.1038/nature12940 · Cited by 1,179
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
Archin, N. M., Liberty, A. L., Kashuba, A. D., Choudhary, S. K., Kuruc, J. D., Crooks, A. M., Parker, D. C., Anderson, E. M., Kearney, M. F., Strain, M. C., et al. (2012) · Nature · doi:10.1038/nature11286 · Cited by 1,139
Green, D. R., & Llambi, F. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a006080 · Cited by 1,101
AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity
Chandarlapaty, S., Sawai, A., Scaltriti, M., Rodrik-Outmezguine, V., Grbovic-Huezo, O., Serra, V., Majumder, P. K., Baselga, J., & Rosen, N. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.10.031 · Cited by 967
Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies
Kim, H., Rafiuddin-Shah, M., Tu, H.-C., Jeffers, J. R., Zambetti, G. P., Hsieh, J. J.-D., & Cheng, E. H.-Y. (2006) · Nature Cell Biology · doi:10.1038/ncb1499 · Cited by 874
Specific HIV integration sites are linked to clonal expansion and persistence of infected cells
Maldarelli, F., Wu, X., Su, L., Simonetti, F. R., Shao, W., Hill, S., Spindler, J., Ferris, A. L., Mellors, J. W., Kearney, M. F., et al. (2014) · Science · doi:10.1126/science.1254194 · Cited by 849
In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency
Chun, T.-W., Finzi, D., Margolick, J., Chadwick, K., Schwartz, D., & Siliciano, R. F. (1995) · Nature Medicine · doi:10.1038/nm1295-1284 · Cited by 787
Upton, J. W., Kaiser, W. J., & Mocarski, E. S. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.01.016 · Cited by 758 · cited 1×
“Alternatively, other death receptors such as the toll like receptors (TLRs) and the cytosolic DNA sensor DNA-dependent activator of IFN regulator genes (DAI) have also been shown to induce necroptosis (Kim et al, 2001; Upton et al, 2012).”
BackgroundShan, L., Deng, K., Shroff, N. S., Durand, C. M., Rabi, S. A., Yang, H.-C., Zhang, H., Margolick, J. B., Blankson, J. N., & Siliciano, R. F. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.014 · Cited by 714
Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection
Wagner, T. A., McLaughlin, S., Garg, K., Cheung, C. Y. K., Larsen, B. B., Styrchak, S., Huang, H. C., Edlefsen, P. T., Mullins, J. I., & Frenkel, L. M. (2014) · Science · doi:10.1126/science.1256304 · Cited by 677
Rasmussen, T. A., Tolstrup, M., Brinkmann, C. R., Olesen, R., Erikstrup, C., Solomon, A., Winckelmann, A., Palmer, S., Dinarello, C., Buzon, M., et al. (2014) · The Lancet HIV · doi:10.1016/s2352-3018(14)70014-1 · Cited by 628
Self-citationBCL-2 family antagonists for cancer therapy
Lessene, G., Czabotar, P. E., & Colman, P. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2658 · Cited by 621
Deeks, S. G. (2012) · Nature · doi:10.1038/487439a · Cited by 604
Stepwise Activation of BAX and BAK by tBID, BIM, and PUMA Initiates Mitochondrial Apoptosis
Kim, H., Tu, H.-C., Ren, D., Takeuchi, O., Jeffers, J. R., Zambetti, G. P., Hsieh, J. J.-D., & Cheng, E. H.-Y. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.030 · Cited by 600
Immune checkpoint blockade in infectious diseases
Wykes, M. N., & Lewin, S. R. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.112 · Cited by 570
Self-citationPierson, T., McArthur, J., & Siliciano, R. F. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.665 · Cited by 545
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
Søgaard, O. S., Graversen, M. E., Leth, S., Olesen, R., Brinkmann, C. R., Nissen, S. K., Kjaer, A. S., Schleimann, M. H., Denton, P. W., Hey-Cunningham, W. J., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005142 · Cited by 516
IFI16 DNA Sensor Is Required for Death of Lymphoid CD4 T Cells Abortively Infected with HIV
Monroe, K. M., Yang, Z., Johnson, J. R., Geng, X., Doitsh, G., Krogan, N. J., & Greene, W. C. (2014) · Science · doi:10.1126/science.1243640 · Cited by 511
Verdin, E., Paras, P., & Van Lint, C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05994.x · Cited by 510
Elliott, J. H., Wightman, F., Solomon, A., Ghneim, K., Ahlers, J., Cameron, M. J., Smith, M. Z., Spelman, T., McMahon, J., Velayudham, P., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004473 · Cited by 504
Self-citationBroad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
Deng, K., Pertea, M., Rongvaux, A., Wang, L., Durand, C. M., Ghiaur, G., Lai, J., McHugh, H. L., Hao, H., Zhang, H., et al. (2015) · Nature · doi:10.1038/nature14053 · Cited by 504
Redefining the Viral Reservoirs that Prevent HIV-1 Eradication
Eisele, E., & Siliciano, R. F. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.010 · Cited by 474
mTOR Kinase Inhibition Causes Feedback-Dependent Biphasic Regulation of AKT Signaling
Rodrik-Outmezguine, V. S., Chandarlapaty, S., Pagano, N. C., Poulikakos, P. I., Scaltriti, M., Moskatel, E., Baselga, J., Guichard, S., & Rosen, N. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0085 · Cited by 442
Re-emergence of HIV after stopping therapy
Chun, T.-W., Davey, R. T., Engel, D., Lane, H. C., & Fauci, A. S. (1999) · Nature · doi:10.1038/44755 · Cited by 428
Apoptosis-based therapies for hematologic malignancies
Reed, J. C., & Pellecchia, M. (2005) · Blood · doi:10.1182/blood-2004-07-2761 · Cited by 402
She, Q.-B., Halilovic, E., Ye, Q., Zhen, W., Shirasawa, S., Sasazuki, T., Solit, D. B., & Rosen, N. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.023 · Cited by 400 · cited 1×
“Binding of the Pleckstrin homology (PH) domain of Akt to the phosphoinositide products of PI3K (PIP3) results in the recruitment of Akt to the plasma membrane and Akt activation (She et al, 2010).”
BackgroundWandeler, G., Johnson, L. F., & Egger, M. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000298 · Cited by 399
Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis
Annis, M. G., Soucie, E. L., Dlugosz, P. J., Cruz‐Aguado, J. A., Penn, L. Z., Leber, B., & Andrews, D. W. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600675 · Cited by 376
Clonally expanded CD4 + T cells can produce infectious HIV-1 in vivo
Simonetti, F. R., Sobolewski, M. D., Fyne, E., Shao, W., Spindler, J., Hattori, J., Anderson, E. M., Watters, S. A., Hill, S., Wu, X., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522675113 · Cited by 372
An Integrated Overview of HIV-1 Latency
Ruelas, D. S., & Greene, W. C. (2013) · Cell · doi:10.1016/j.cell.2013.09.044 · Cited by 324
Chew, G. M., Fujita, T., Webb, G. M., Burwitz, B. J., Wu, H. L., Reed, J. S., Hammond, K. B., Clayton, K. L., Ishii, N., Abdel-Mohsen, M., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005349 · Cited by 323
Carter, C. C., Onafuwa-Nuga, A., McNamara, L. A., Riddell, J., Bixby, D., Savona, M. R., & Collins, K. L. (2010) · Nature Medicine · doi:10.1038/nm.2109 · Cited by 317
Wolf, D., Witte, V., Laffert, B., Blume, K., Stromer, E., Trapp, S., d'Aloja, P., Schürmann, A., & Baur, A. S. (2001) · Nature Medicine · doi:10.1038/nm1101-1217 · Cited by 297
Elliott, J. H., McMahon, J. H., Chang, C. C., Lee, S. A., Hartogensis, W., Bumpus, N., Savic, R., Roney, J., Hoh, R., Solomon, A., et al. (2015) · The Lancet HIV · doi:10.1016/s2352-3018(15)00226-x · Cited by 250
Self-citationCD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses
Descours, B., Petitjean, G., López-Zaragoza, J.-L., Bruel, T., Raffel, R., Psomas, C., Reynes, J., Lacabaratz, C., Levy, Y., Schwartz, O., et al. (2017) · Nature · doi:10.1038/nature21710 · Cited by 242
Bui, J. K., Sobolewski, M. D., Keele, B. F., Spindler, J., Musick, A., Wiegand, A., Luke, B. T., Shao, W., Hughes, S. H., Coffin, J. M., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006283 · Cited by 241
de Almagro, M. C., & Vucic, D. (2012) · PubMed · Cited by 237
The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival
Cooray, S. (2004) · Journal of General Virology · doi:10.1099/vir.0.19771-0 · Cited by 229
Mbonye, U., & Karn, J. (2014) · Virology · doi:10.1016/j.virol.2014.02.008 · Cited by 228
Small-molecule SMAC mimetics as new cancer therapeutics
Bai, L., Smith, D. C., & Wang, S. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.05.007 · Cited by 210
Jones, R. B., O'Connor, R., Mueller, S., Foley, M., Szeto, G. L., Karel, D., Lichterfeld, M., Kovacs, C., Ostrowski, M. A., Trocha, A., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004287 · Cited by 206
Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy
Gutiérrez, C., Serrano-Villar, S., Madrid-Elena, N., Pérez-Elías, M. J., Martín, M. E., Barbas, C., Ruipérez, J., Muñoz, E., Muñoz-Fernández, M. A., Castor, T., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001064 · Cited by 203
Solis, M., Nakhaei, P., Jalalirad, M., Lacoste, J., Douville, R., Arguello, M., Zhao, T., Laughrea, M., Wainberg, M. A., & Hiscott, J. (2011) · Journal of Virology · doi:10.1128/jvi.01635-10 · Cited by 200
Spivak, A. M., Andrade, A., Eisele, E., Hoh, R., Bacchetti, P., Bumpus, N. N., Emad, F., Buckheit, R., McCance-Katz, E. F., Lai, J., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit813 · Cited by 200
Xing, S., Bullen, C. K., Shroff, N. S., Shan, L., Yang, H.-C., Manucci, J. L., Bhat, S., Zhang, H., Margolick, J. B., Quinn, T. C., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02033-10 · Cited by 197
BH3-only proteins in apoptosis at a glance
Happo, L., Strasser, A., & Cory, S. (2012) · Journal of Cell Science · doi:10.1242/jcs.090514 · Cited by 193
Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency
Archin, N. M., Kirchherr, J. L., Sung, J. A. M., Clutton, G., Sholtis, K., Xu, Y., Allard, B., Stuelke, E., Kashuba, A. D., Kuruc, J. D., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92684 · Cited by 190
Clinical course of primary HIV infection: consequences for subsequent course of infection.
Pedersen, C., Lindhardt, B. O., Jensen, B. L., Lauritzen, E., Gerstoft, J., Dickmeiss, E., Gaub, J., Scheibel, E., & Karlsmark, T. (1989) · BMJ · doi:10.1136/bmj.299.6692.154 · Cited by 184
The Molecular Basis for Human Immunodeficiency Virus Latency
Mbonye, U., & Karn, J. (2017) · Annual Review of Virology · doi:10.1146/annurev-virology-101416-041646 · Cited by 182
Histone acetyltransferases regulate HIV-1 enhancer activity in vitro
Sheridan, P. L., Mayall, T. P., Verdin, E., & Jones, K. A. (1997) · Genes & Development · doi:10.1101/gad.11.24.3327 · Cited by 179
Leth, S., Schleimann, M. H., Nissen, S. K., Højen, J. F., Olesen, R., Graversen, M. E., Jørgensen, S., Kjær, A. S., Denton, P. W., Mørk, A., et al. (2016) · The Lancet HIV · doi:10.1016/s2352-3018(16)30055-8 · Cited by 177
Cell Survival and Apoptosis Signaling as Therapeutic Target for Cancer: Marine Bioactive Compounds
Kalimuthu, S., & Kim, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14022334 · Cited by 161
Jones, R. B., Mueller, S., O’Connor, R., Rimpel, K., Sloan, D. D., Karel, D., Wong, H. C., Jeng, E. K., Thomas, A. S., Whitney, J. B., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005545 · Cited by 160
Tsai, A., Irrinki, A., Kaur, J., Cihlář, T., Kukolj, G., Sloan, D. D., & Murry, J. P. (2017) · Journal of Virology · doi:10.1128/jvi.02166-16 · Cited by 160
Vibholm, L. K., Schleimann, M. H., Højen, J. F., Benfield, T., Offersen, R., Rasmussen, K., Olesen, R., Dige, A. K., Agnholt, J. S., Grau-Expósito, J., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix201 · Cited by 155
Rasmussen, T. A., & Lewin, S. R. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000279 · Cited by 150
Self-citationA Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma
Amaravadi, R. K., Schilder, R. J., Martin, L. P., Levin, M. J., Graham, M. A., Weng, D. E., & Adjei, A. A. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0475 · Cited by 141
Pache, L., Dutra, M. S., Spivak, A. M., Marlett, J. M., Murry, J. P., Hwang, Y., Maestre, A. M., Manganaro, L., Vamos, M., Teriete, P., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.08.009 · Cited by 137
Histone deacetylase inhibitors and HIV latency
Margolis, D. M. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328341242d · Cited by 133
Smac mimetics as new cancer therapeutics
Chen, D. J., & Huerta, S. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32832ced78 · Cited by 132
Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy
Chugh, P., Bradel-Tretheway, B., Monteiro-Filho, C. M., Planelles, V., Maggirwar, S. B., Dewhurst, S., & Kim, B. (2008) · Retrovirology · doi:10.1186/1742-4690-5-11 · Cited by 128
Wightman, F., Solomon, A. E., Khoury, G., Green, J. A., Gray, L. R., Gorry, P. R., Ho, Y. S., Saksena, N. K., Hoy, J., Crowe, S. M., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/656721 · Cited by 128
Self-citationEliminating hepatitis B by antagonizing cellular inhibitors of apoptosis
Ebert, G., Allison, C. C., Preston, S., Cooney, J. P., Toe, J. G., Stutz, M. D., Ojaimi, S., Baschuk, N., Nachbur, U., Torresi, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502400112 · Cited by 122
Noonan, A. M., Bunch, K. P., Chen, J., Herrmann, M. A., Lee, J., Kohn, E. C., O'Sullivan, C. C., Jordan, E., Houston, N. D., Takebe, N., et al. (2015) · Cancer · doi:10.1002/cncr.29783 · Cited by 120
IAPs, regulators of innate immunity and inflammation
Estornes, Y., & Bertrand, M. J. M. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.03.035 · Cited by 116
Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation
Li, P., Kaiser, P. D., Lampiris, H. W., Kim, P., Yukl, S. A., Havlir, D. V., Greene, W. C., & Wong, J. K. (2016) · Nature Medicine · doi:10.1038/nm.4124 · Cited by 108
Laukens, B., Jennewein, C., Schenk, B., Vanlangenakker, N., Schier, A., Cristofanon, S., Zobel, K., Deshayes, K., Vucic, D., Jeremias, I., et al. (2011) · Neoplasia · doi:10.1593/neo.11610 · Cited by 107
Cummins, N. W., Sainski, A. M., Dai, H., Natesampillai, S., Pang, Y., Bren, G. D., Correia, M. C. M. D. A., Sampath, R., Rizza, S. A., O’Brien, D. R., et al. (2016) · Journal of Virology · doi:10.1128/jvi.03179-15 · Cited by 104
Offersen, R., Nissen, S. K., Rasmussen, T. A., Østergaard, L. J., Denton, P. W., Søgaard, O. S., & Tolstrup, M. (2016) · Journal of Virology · doi:10.1128/jvi.00222-16 · Cited by 103
Wang, F., Gao, X., Barrett, J. W., Shao, Q., Bartee, E., Mohamed, M. R., Rahman, M. M., Werden, S. J., Irvine, T. S., Cao, J., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000099 · Cited by 98
Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus
Ebert, G., Preston, S., Allison, C. C., Cooney, J. P., Toe, J. G., Stutz, M. D., Ojaimi, S., Scott, H. W., Baschuk, N., Nachbur, U., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502390112 · Cited by 96
Busca, A., Saxena, M., & Kumar, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.312660 · Cited by 84
BCL2 Family, Mitochondrial Apoptosis, and Beyond
Dai, H., Meng, W., & Kaufmann, S. H. (2016) · Cancer translational medicine · doi:10.4103/2395-3977.177558 · Cited by 82
Smac mimetics as IAP antagonists
Fulda, S. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.12.005 · Cited by 81
Aillet, F., Masutani, H., Elbim, C., Raoul, H., Chêne, L., Nugeyre, M.-T., Payá, C. V., Barré‐Sinoussi, F., Gougerot‐Pocidalo, M., & Israël, N. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9698-9705.1998 · Cited by 80
Necroptosis Takes Place in Human Immunodeficiency Virus Type-1 (HIV-1)-Infected CD4+ T Lymphocytes
Pan, T. S., Wu, S., He, X., Luo, H., Zhang, Y., Fan, M., Geng, G., Ruiz, V. C., Zhang, J., Mills, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093944 · Cited by 80
How do viruses control mitochondria-mediated apoptosis?
Neumann, S., Maadidi, S. E., Faletti, L. E., Haun, F., Labib, S., Schejtman, A., Maurer, U., & Borner, C. (2015) · Virus Research · doi:10.1016/j.virusres.2015.02.026 · Cited by 80
Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV Infection
Soriano-Sarabia, N., Archin, N. M., Bateson, R., Dahl, N., Crooks, A. M., Kuruc, J. D., Garrido, C., & Margolis, D. M. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005201 · Cited by 77
HIV Infection of Macrophages: Implications for Pathogenesis and Cure
Clayton, K., Garcia, V., Clements, J. E., & Walker, B. D. (2017) · Pathogens and Immunity · doi:10.20411/pai.v2i2.204 · Cited by 77
Identifying the Membrane Proteome of HIV-1 Latently Infected Cells
Berro, R., de la Fuente, C., Klase, Z., Kehn, K., Parvin, L., Pumfery, A., Agbottah, E., Vertes, A., Nekhai, S., & Kashanchi, F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606324200 · Cited by 72
Petit, F., Arnoult, D., Lelièvre, J., Parseval, L. M., Hance, A. J., Schneider, P., Corbeil, J., Ameisen, J. C., & Estaquier, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m102671200 · Cited by 71
Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition
Cummins, N. W., Sainski-Nguyen, A. M., Natesampillai, S., Aboulnasr, F., Kaufmann, S. H., & Badley, A. D. (2017) · Journal of Virology · doi:10.1128/jvi.00012-17 · Cited by 71
Rosato, R. R., Almenara, J. A., Kolla, S. S., Maggio, S. C., Coe, S., Giménez, M. S., Dent, P., & Grant, S. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0562 · Cited by 67
Current HIV Treatment Guidelines - An Overview
Rathbun, R. C., Lockhart, S., & Stephens, J. R. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776055840 · Cited by 65
Kim, N., Kukkonen, S. K. J., Gupta, S., & Aldovini, A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001103 · Cited by 55
Pace, M. J., Williams, J., Kurioka, A., Gerry, A. B., Jakobsen, B. K., Klenerman, P., Nwokolo, N. C., Fox, J., Fidler, S. J., Frater, J., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005782 · Cited by 54
Apoptosis by pan-caspase inhibitors in lipopolysaccharide-activated macrophages
Kim, S. O., Ono, K., & Han, J. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.5.l1095 · Cited by 49
Molecular Understanding of HIV-1 Latency
Abbas, W., & Herbein, G. (2012) · Advances in Virology · doi:10.1155/2012/574967 · Cited by 49
Timilsina, U., & Gaur, R. (2016) · Journal of General Virology · doi:10.1099/jgv.0.000402 · Cited by 42
Bcl-2 antagonists: a proof of concept for CLL therapy
Balakrishnan, K., & Gandhi, V. V. (2013) · Investigational New Drugs · doi:10.1007/s10637-013-0002-4 · Cited by 39
RIG-I activation inhibits HIV replication in macrophages
Wang, Y., Wang, X., Li, J., Zhou, Y., & Ho, W. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0313158 · Cited by 36
Awan, F. T., Jones, J. A., Maddocks, K. J., Poi, M. J., Grever, M. R., Johnson, A. J., Byrd, J. C., & Andritsos, L. A. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2683-1 · Cited by 36
Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation
Sainski, A. M., Dai, H., Natesampillai, S., Pang, Y., Bren, G. D., Cummins, N. W., Correia, C., Meng, X. W., Tarara, J. E., Ramírez-Alvarado, M., et al. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201405051 · Cited by 34
Cyclin-dependent kinase inhibitors for the treatment of chronic lymphocytic leukemia
Blachly, J. S., Byrd, J. C., & Grever, M. R. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2016.02.003 · Cited by 28
Challenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV Reservoirs
Brockman, M. A., Jones, R. B., & Brumme, Z. L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00506 · Cited by 23
Experimental Approaches for Eliminating Latent HIV
Marsden, M. D., & Zack, J. A. (2015) · Forum on Immunopathological Diseases and Therapeutics · doi:10.1615/forumimmundisther.2016015242 · Cited by 22
Ma, A. W., Atoyan, R., Younes, A., Flinn, I. W., Oki, Y., Copeland, A. R. M., Berdeja, J. G., Laliberte, R. J., Viner, J. L., Samson, M., et al. (2014) · Cancer Research · doi:10.1158/1538-7445.am2014-1879 · Cited by 3
Cited by
Necroptosis, pyroptosis and apoptosis: an intricate game of cell death
Bertheloot, D., Latz, E., & Franklin, B. S. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00630-3 · Cited by 2,166
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
Deeks, S. G., Archin, N., Cannon, P., Collins, S., Jones, R. B., de Jong, M. A. W. P., Lambotte, O., Lamplough, R., Ndung’u, T., Sugarman, J., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01590-5 · Cited by 377
Self-citationMicroglial Cells: The Main HIV-1 Reservoir in the Brain
Wallet, C., De Rovere, M., Van Assche, J., Daouad, F., De Wit, S., Gautier, V., Mallon, P. W. G., Marcello, A., Van Lint, C., Rohr, O., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00362 · Cited by 368
Targeting the Latent Reservoir for HIV-1
Sengupta, S., & Siliciano, R. F. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.030 · Cited by 340
The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies
Cohn, L. B., Chomont, N., & Deeks, S. G. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.03.014 · Cited by 284
Metadata
- Authors
- Kim, Y., Anderson, J. L., & Lewin, S. R.
- Venue
- Cell Host & Microbe
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 23
- Issue
- 1
- Pages
- 14-26
- ISSN
- 1931-3128 (ISSN-L)
- OpenAlex
- W2782696110
- Cited by
- 414
- References
- 126
- FWCI
- 22.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.